Amgen (AMGN) Cash from Investing Activities (2009 - 2026)

Amgen (AMGN) has reported Cash from Investing Activities for 18 consecutive years, with -$716.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 60.18% year-over-year to -$716.0 million; the TTM figure through Mar 2026 stood at -$2.2 billion (down 73.35% YoY), while the FY2025 annual figure was -$1.9 billion, down 85.76% from the prior year.
• Cash from Investing Activities came in at -$716.0 million for Q1 2026 at Amgen, down from -$693.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $1.4 billion in Q1 2023, with the low at -$27.1 billion in Q4 2023.
• Average Cash from Investing Activities over 5 years is -$2.1 billion, with a median of -$389.0 million recorded in 2025.
• Across the five-year window, Cash from Investing Activities slumped 1410.0% in 2022 and soared 1323.42% in 2023, its largest moves.
• Year by year, Cash from Investing Activities stood at -$3.5 billion in 2022, then slumped by 679.99% to -$27.1 billion in 2023, then jumped by 98.52% to -$402.0 million in 2024, then sank by 72.39% to -$693.0 million in 2025, then retreated by 3.32% to -$716.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$716.0 million, -$693.0 million, and -$414.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.